1. Home
  2. |Insights
  3. |Challenges and Opportunities for Health Care Companies in a Changing Global Trade Environment

Challenges and Opportunities for Health Care Companies in a Changing Global Trade Environment

Webinar | March 27, 2025

Address

Virtual

Register Here

Please join Crowell Global Advisors for a roundtable discussion with health care industry and international trade experts on President Trump’s trade policy and how it affects players in the health care industry. As April 2nd approaches and the President has repeatedly cited his intention to raise tariffs on medical products, this discussion will provide guidance for companies throughout the healthcare value chain. We will also take questions from listeners. 

Discussion topics will include: 

  • Risks and resilience strategies in the medical supply chain
  • Tariffs, trade imbalances and national security considerations
  • Opportunities to engage policymakers proactively to address tariffs and advance market access
  • Key country-specific considerations: Mexico, India, China, EU
  • Global health care collaboration in a fragmenting world

For more information, please visit these areas: Crowell Global Advisors, Government Affairs, International Trade, Health Care

Participants

Insights

Webinar | 10.16.25

The Artificial Intelligence Agenda from Capitol Hill to State Capitals: Where We Are and Where We Are (Probably) Going

The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:...

View All Insights